Summary In the present study, the expression of the epidermal growth factor receptor (EGFR) was investigated in putative preneoplastic and neoplastic acinar cell lesions induced in the rat pancreas by azaserine, using Northern blotting, in situ hybridisation (ISH) and immunohistochemistry. EGFR protein levels were decreased in putative preneoplastic eosinophilic acinar cell lesions (atypical acinar cell nodules, AACN) in comparison with normal acinar cells of the pancreas. However, EGFR mRNA expression correlated positively with the volume of AACN in pancreatic homogenates and ISH showed equal or stronger EGFR mRNA expression in AACN than in the surrounding normal acinar cells. Neither EGFR protein nor EGFR mRNA was detected in more advanced lesions such as acinar adenocarcinomas (in situ). Moreover, EGFR protein expression showed an inverse relationship with the mitotic rate of the acinar cells. These findings suggest that down-regulation of EGFR at the protein level may abrogate negative constraints on cell growth, which may stimulate the development of putative preneoplastic AACN to more advanced lesions and, ultimately, acinar adenocarcinomas.
Despite an increasing number of advanced diagnostic techniques and new therapies, the 5 year survival rate of patients with tumours of the exocrine pancreas is not more than 3% (Warshaw and Castillo, 1992) . This poor prognosis is mainly due to late diagnosis and the absence of effective therapeutic modalities. Therefore, there is a need for studies on pancreatic cancer that concentrate on the detection of modulating factors involved early in the carcinogenic process. As originally proposed by Temin (1966) , one of the causes of the uncontrolled proliferative character of tumours might be inappropriate autocrine or paracrine production of growth factor (receptor)s (Lang and Burgess, 1990) . The epidermal growth factor receptor (EGFR) is believed to be one of these factors (Elder, 1994) . In non-transformed (normal) cells, EGFR expression generally appears to be regulated within a rather narrow range of 20 000-100 000 receptors per cell (Velu, 1990) . In both normal and transformed keratinocytes, EGFR expression is regulated at several levels, including transcription, mRNA stability, translation and post-translational modification (Pas et al., 1991) . In certain tumour cell lines, such as the A431 epidermoid carcinoma cell line, EGFR mRNA and protein levels are markedly increased as a result of amplification of the EGFR gene (Merlino et al., 1984) . EGFR is also overexpressed in several human pancreatic cancer cell lines Gamou et al., 1984) , as well as in the pancreas of patients with pancreatic cancer and chronic pancreatitis (Lemoine et al., 1992; Smith et al., 1987) . Overexpression of EGFR in human pancreatic tumours has been associated with an autocrine cell growth stimulation cycle (Lemoine et al., 1992; Smith et al., 1987; Korc et al., 1992) . Furthermore, the v-erbB protooncogene of the avian erythroblastosis virus encodes a protein resembling EGFR (Downward et al., 1984) , supporting the oncogenic potential of EGFR.
In the present study, the expression of EGFR was characterised in putative preneoplastic atypical acinar cell lesions (AACN) and in acinar tumours induced in rat pancreas by azaserine (Longnecker, 1983; Scherer et al., 1989 (Figure 3a) , carcinomas in situ and acinar adenocarcinomas were negative. The AACN exhibited a large variation in their intensity of EGFR immunoreactivity (Figure 2 ), which was found predominantly in the cytoplasm in these lesions since hardly any immunoreactivity to EGFR was present on the cellular membranes. The AACN also varied in number of cells with immunoreactivity to EGFR. In some lesions only a few dispersed cells were positive, whereas other lesions showed an almost similar immunoreactivity to EGFR as the surrounding normal acinar cells. Figure 2 demonstrates clearly the variance in EGFR immunoreactivity within one pancreas tissue section, ranging from hardly any staining through a staining intensity similar to normal acinar cells. In general, larger (more advanced) atypical acinar cell lesions, when Figure 2 Immunohistochemical localisation of EGFR in azaserine-treated rat pancreas. Note differences in intensities of EGFR in the putative preneoplastic lesions. P, putative preneoplastic atypical acinar cell nodule. The antibody used is MAb 29.1 (Sigma); bar = 400 im. Figure 1 Immunohistochemical localisation of EGFR in Figure 3 Immunohistochemical localisation of (a) EGFR and (b) azaserine-treated rat pancreas. I, islet of Langerhans cells; A, PCNA, in azaserine-treated rat pancreas. A, normal pancreas normal pancreas acinar cells; P, putative preneoplastic atypical acinar cells; P, putative preneoplastic atypical acinar cell nodule acinar cell nodule; arrowheads point to membranous staining.
(primary lesion); N, nodule-in-nodule (secondary lesion (Figure 3b ). In contrast with the putative preneoplastic eosinophilic atypical acinar cell foci, the basophilic atypical acinar cell foci (which are not considered to be preneoplastic) could not be distinguished from normal acinar cells by incubation with either the anti-EGFR antibodies or the PCNA antibody (not shown). Sections of the rat submaxillary and sublingual salivary glands were used as controls for the specificity of the anti-EGFR antibodies. As expected, strong immunoreactivity was apparent only on the serous cells. Omitting the anti-EGFR or anti-PCNA first antibodies resulted in complete absence of staining.
Northern blotting A total of 17 rat pancreatic tissues comprising normal and putative preneoplastic acinar cells, and five macroscopically isolated acinar adenocarcinomas were analysed by Northern blotting (Figure 4 ). No differences in EGFR mRNA expression were observed in homogenates from untreated controls or from rats treated with azaserine with no, or a very low number of AACN in their pancreas (observed in parallel sections from the pancreatic pieces used for homogenisation). A significantly positive correlation was found for the EGFR mRNA levels when compared with the number of atypical acinar cell lesions found in parallel sections from the same pancreata (four independent Northern blots: r=0.9950, P<0.05; r=0.9993, P<0.01; r=0.85263; P<0.05; r=0.9953, P<0.05). However, no EGFR mRNA expression was detected by Northern blotting on total RNA from the isolated acinar adenocarcinomas, whereas ethidium bromide staining intensity and 7S control signal were equally detectable (Figure 4 ). In situ hybridisation Hybridisation of rat pancreas sections with the 33P-labelled rat EGFR riboprobe revealed a positive signal in the acinar cells of normal pancreas, whereas no grains could be observed in the ductular (Figure 5a , exposure time 10 days) and endocrine cells (not shown). Furthermore, putative preneoplastic atypical acinar cell nodules exhibited a similar number or even more grains than the normal acinar cells (Figure 5b , exposure time 5 days). However, in more advanced lesions (e.g. carcinoma in situ), EGFR mRNA was only faintly detectable ( Figure 5c , exposure time 10 days) or undetectable. When the sections were pretreated with RNAase, no differences in signals were observed between normal, preneoplastic or neoplastic tissues; the few remaining grains were considered to represent background (Figure 5d , exposure time 10 days).
Discussion
Using immunohistochemistry, Northern blotting, and in situ hybridisation, the present study clearly demonstrates that epidermal growth factor receptors (EGFRs) are detectable on pancreatic acinar cells of normal rats and of rats treated with azaserine, as summarised in Table I It cannot be excluded that diminished EGFR immunoreactivity as observed in the present study is the result of a change of the epitope instead of actual decrease in the number of EGFR present. However, this explanation does not seem to be very likely, since we found similar results with two different monoclonal antibodies directed to the EGFR. Moreover, it has been established that the antibodies used are reactive in rats since they demonstrate a positive reaction with salivary glands collected from the same animals.
It is conceivable that the findings presented in this paper are typical for acinar pancreatic cells only and may very well not apply for ductular pancreatic cells or ductular adenocarcinomas of the pancreas. To our knowledge, human acinar adenocarcinomas have not been investigated for the presence of EGFR. Similar experiments to those described in this paper are performed in our Institute with N-nitrosobis(2-oxopropyl)amine-treated hamsters as a model for ductular adenocarcinomas (Pour and Wilson, 1980) , in order to investigate whether EGFR might play a role in the development of pancreatic ductular carcinomas.
Decreased EGFR-mediated signalling may thus lead to intensities between sections are due to differences in exposure times; bar= 50 ,m. loss of differentiated functions and increased propensity toward neoplastic transformation. Indeed, several lines of evidence suggest an anti-mitogenic role for EGFR in the rat exocrine pancreas. First, the rat pancreatic acinar cell has specific high-affinity EGF receptors (Korc et al., 1983) , and EGF is necessary for the maintainance of this cell type in serum-free culture (Brannon et al., 1985) . Second, EGF enhances rat acinar cell survival and pancreatic protein synthesis at concentrations as low as 42 pM (Brannon et al., 1985; 1986; . Third, this action of EGF is relatively specific, inasmuch as a similar effect occurs only at 2.7 nM IGF-1 and does not occur with insulin (Brannon et al., 1988) . Fourth, EGF decreases thymidine incorporation into pancreatic DNA in male, Sprague-Dawley rats (Morisset et al., 1989) and increases pancreatic content of amylase and chymotrypsinogen while preventing caerulein-mediated desensitisation of the acinar cell secretory responsiveness (Morisset et al., 1989) . Fifth, EGF binding is decreased in the regenerating rat pancreas following 90% pancreatectomy, in parallel with an increase in acinar cell mitotic activity (Brockenbrough et al., 1988) . Sixth, the results of a recent study performed by our group demonstrated that putative preneoplastic atypical acinar cell lesions may develop into acinar adenocarcinomas independently of TGF-az or EGF (Visser et al., 1995) . Thus, a decrease in EGFR-mediated signalling in the rat pancreatic acinar cell may lead to enhanced carcinogenesis.
However, another explanation could be that cells within the neoplastic lesion may have accumulated other genetic alterations e.g. in other members of the EGFR family, such as c-erbB-2 (HER-2, ERBB2, neu; Yamamoto et al., 1986; Coussens et al., 1985; Stern et al., 1986) or ERBB3 (Kraus et al., 1989; Plowman et al., 1990) , driving cell division without the necessity for EGFR signalling. Consequently, the EGFR gene is generally switched off in the malignant adenocarcinoma cells.
